Rusan Pharma secures Japan PMDA GMP approval for API, FDF facilities
PMDA is regarded among the most stringent regulatory bodies globally
PMDA is regarded among the most stringent regulatory bodies globally
Bidding window open till May 15; study to map costs and bottlenecks across pharma supply chains
The upcoming multi-center, multinational Phase 1 study will evaluate safety, tolerability, pharmacokinetics, and early signs of efficacy
Minister highlights scope for domestic manufacturing during his meeting with Dr Niti Pall, President-elect, International Diabetes Federation
DBT-BIRAC, BioE3 and the Rs 10,000-crore Biopharma SHAKTI scheme aim to accelerate innovation, biomanufacturing and exports
Price of the starting dose of Ozempic and Wegovy reduced by 36% and 48% respectively
One task, one interaction, one pair, experts advocate
The funding comes under the AHG Catalysing Innovation Awards, part of the Addiction Healthcare Goals programme led by the Office for Life Sciences
Subscribe To Our Newsletter & Stay Updated